Employers Pull Back GLP-1 Drug Coverage as Costs Rise
WTW found that only 53% of U.S. employers now fund GLP-1 medicines for weight loss, marking the first retreat since their weight-loss use took off three years back. For contrast, WTW reported that 57% of employers funded the drugs in 2025. The consultants also reported that 30% of employers who…